Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
See Latest ArticlesAmifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
Cochrane Reviews, 10/09/09
Ma C et al. – Amifostine is thought to be a radioprotector of salivary glands used in conjunction with radioiodine therapy. This medication is administered intravenously and was reported to ameliorate the damage of salivary glands caused by radioactive iodine therapy...The authors found only two randomised controlled trials in which the effects of amifostine were compared with placebo. Results from two randomised controlled clinical trials suggest that the amifostine has no significant radioprotective effects on salivary glands in high–dose radioactive iodine treated differentiated thyroid cancer patients. Moreover, no health–related quality of life and other patient–oriented outcomes were evaluated in the two included trials. Randomised controlled clinical trials with low risk of bias investigating patient–oriented outcomes are needed to guide treatment choice.
Related Articles
Neurofibroma adjacent to the thyroid gland and a thyroid papillary carcinoma in a patient with neurofibromatosis type 1: Report of a case
Surgery Today, 10/06/09
Relevance Score: 81%
Assessment of angiogenesis by CD105 antigen in epithelial salivary gland neoplasms with diverse metastatic behavior
BMC Cancer, 11/13/09
Relevance Score: 80%
Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
European Journal of Endocrinology, 10/06/09
Relevance Score: 79%
Development and application of magnetic resonance elastography of the normal and pathological thyroid gland in vivo
Journal of Magnetic Resonance Imaging, 11/09/09
Relevance Score: 68%
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Laryngeal steroid injection
Current Opinion in Otolaryngology and Head & Neck Surgery, 11/20/09
Ceftriaxone for Refractory Acute Otitis Media: Impact of a Clinical Practice Guideline
Pediatric Emergency Care, 11/17/09
Propranolol treatment for infantile hemangiomas
Current Opinion in Otolaryngology and Head & Neck Surgery, 11/13/09
Today in Salivary Glands...keeping you current
Receive free subspecialty "5-minute updates" via email
Sclerosing mucoepidermoid carcinoma of the parotid gland: Case report
ENT Journal, 11/20/09
Expression of matrix metalloproteinase-1, -7, -9, -13, Ki-67, and HER-2 in epithelial-myoepithelial salivary gland cancer
Head & Neck, 11/13/09
Parotid lymphoma in west Scotland: two-year snapshot of diagnosis, management and core issues
The Journal of Laryngology & Otology, 11/03/09
Article Search
Sponsor